EXHIBIT 2.11


                                                         July 25, 2000


Mr. Craig S. Kussman
Executive Vice President and Chief Financial Officer
Synavant, Inc.


Dear Mr. Kussman:

IMS Health Incorporated (IMS) shall support the working capital requirements of
the Synavant Business (such business as described in the Form 10 and the related
Synavant combined financial statements). Heretofore the Synavant Business has
been operating under IMS and has been receiving financing from IMS, where
required, for its operating needs. To expedite the Distribution, IMS shall
ensure that Synavant Inc. will have a line of credit from a major bank or
financial institution in place on the Distribution Date. This line of credit
will be supported by IMS in connection with the Distribution in an amount not to
exceed $30 million and, along with existing cash, financial resources and the
working capital adjustment on the Distribution Date (such date as defined in the
Form 10), will be sufficient for Synavant to execute its operations and short
term business plan. Subject to the foregoing, we shall provide credit support
sufficient to meet the working capital needs of Synavant for up to one year from
the Distribution Date (the "Anniversary Date") if necessary, PROVIDED HOWEVER,
that at such time as Synavant has secured an independent line of credit during
the one year post-Distribution period that matures beyond the Anniversary Date
without IMS credit support and which satisfies the foregoing criteria, IMS'
credit support commitment shall immediately terminate.



James C. Malone
Chief Financial Officer
IMS Health, Inc.



Cc:  PricewaterhouseCoopers
         Vickie Fash
         Wayne Yetter